Vexim, the Med-Tech specialist in the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it has obtained the registration certificate for SpineJack in India. The company will market the SpineJack in India as soon it receives the import license from the Indian authorities.
"This registration certificate shows, once again, SpineJack's conformity to the requirements of the worldwide market. Even if the deployment of SpineJack in Europe is our first priority, and that deployment is progressing with increasing success given the interest that SpineJack is generating in the global market, we will continue to reply favorably to demand for this product coming from other markets. This is the case for India today and this registration certificate, completed by a pending import license, will soon enable Vexim to start commercializing SpineJack in that market thanks to our local distributor," emphasized Vexim's President and CEO Bruce de la Grange.